When co-founders Dr. Mona Potter and Dr. Kat Boger met more than a decade ago, these Harvard-trained innovators shared a commitment to improving mental health care for adolescents. Too often they saw kids labeled as “delinquents” or “troublemakers” who were really dealing with undiagnosed anxiety—and not receiving the specific treatment they needed.
The program delivered superior outcomes and was soon attracting families from around the world. It was so successful, they couldn’t make room fast enough, and there were few comparable programs for the families waiting for care.
Seeing the size of the need, they asked themselves, “How can we be part of the solution?” The answer was to make specialized anxiety and OCD treatment scalable and accessible. To do that, they enlisted the help of experts who share their passion and purpose. The result is InStride, a new model of virtual mental health care that puts families first.
The InStride team is a diverse mix of leading clinicians, healthcare specialists, digital innovators and experienced entrepreneurs. But they all have something in common—the big-time heart they bring to the table, going above and beyond in whatever they do to make sure InStride care provides hope and healing.
Each individual on our clinical team has been handpicked for expertise in their field, innovative thinking, and a passion to make a difference. They know first-hand the joys and challenges that come with having children and families. And this strengthens their resolve, energizing them to continue innovating and improving so that InStride delivers the compassionate, complete and effective care they would expect for those they love.
Dr. Potter’s expertise is surpassed only by her passion for improving the lives of children and families.
After seeing the outcomes, Dr. Boger knew she needed to bring innovative, research-based treatment to more families.
Dr. Sarvey is a board certified child, adolescent and adult psychiatrist committed to helping the child and adolescent mental health community.
Sheree looks at long-term emotional wellbeing, and develops programs and coaching that support her vision.
Dr. Wilmer is a board-certified cognitive behavioral psychologist who specializes in the treatment of anxiety, OCD, and related disorders.
Dr. Gittins Stone has focused on providing evidence-based assessment and treatment to children, families, and young adults.
These are the experts who keep the wheels turning, ensure that we’re operating at peak efficiency and effectiveness, and ultimately empower InStride to serve more people in need. Each one pours their heart into our mission and works hard (and smart) to make InStride a success—because they know that’s what it takes to help solve the pediatric mental health crisis.
John is driven to preserve—and advance—best-in-the-world clinical quality, while using technology to make it more accessible.
James sees the possibilities that technology creates, and uses his expertise to empower InStride to change the world.
Eileen has devoted the last twenty years of her career to expanding and improving healthcare delivery.
Danielle is driven to reach more children and families and help them live healthier lives.
Mike has experience creating strong teams with disciplined financial analysis to help transform that data into actionable insights.
We rely on experienced and knowledgeable advisors to help keep us on track. Their wisdom, insights and guidance ensure that InStride continues to evolve for the better.
Throughout her nearly two decades of clinical and administrative work in the Harvard medical system, board-certified child and adolescent psychiatrist Dr. Mona Potter witnessed firsthand the challenges families face in navigating the mental health system. She saw the long treatment waitlists, inadequate availability of evidence-based treatment, and lack of transparency in outcomes — and she was motivated to change care for the better.
During her time as the Medical Director of McLean Hospital’s Child and Adolescent Outpatient Services, Dr. Potter co-developed several programs, including the McLean Anxiety Mastery Program (MAMP) and McLean School Consultation Service. With a passion for incorporating cutting-edge technologies into treatment, through her role on the leadership team of the McLean Institute for Technology in Psychiatry (ITP), she helped spearhead the hospital’s telehealth pilot program and use of virtual reality for anxiety exposure therapy.
Building on her experience and expertise as a clinician and a parent, Dr. Potter was motivated to co-found InStride Health to improve access to care, engagement, and treatment outcomes for children and adolescents with moderate to severe anxiety and OCD.
Dr. Potter is widely published in peer-reviewed journals and is a highly sought lecturer. When she’s not brainstorming and sharing ways to improve care delivery, she enjoys summiting mountains, coaching her children’s soccer and Lego League teams, and keeping the music alive while playing piano duets with her family.
A board certified and Harvard-trained child and adolescent clinical psychologist, Dr. Kathryn (“Kat”) Boger has devoted her career to helping children and teens with anxiety and OCD and their families. She is passionate about improving care for youth and decreasing suffering through innovative, research-based treatment approaches. Dr. Boger co-founded the McLean Anxiety Mastery Program (MAMP), nationally recognized for providing empirically-supported, intensive anxiety and OCD treatment.
While at MAMP, Dr. Boger served as program director and had oversight of all levels of program development and refinement. She served as an assistant professor of psychology at Harvard Medical School and has published a variety of peer-reviewed journal articles, delivered regional and national talks (including a TEDx) and provided training to hospitals, schools, and the community.
Dr. Boger was tired of watching families sit on long treatment waitlists while their child’s symptoms worsened. She is thrilled to co-found InStride Health in order to reach more children, teens, and young adults with anxiety and OCD and provide them with the right care when they need it most.
As a mom to three energetic boys, Dr. Boger’s favorite non-work activities are playing soccer and most other sports, baking cookies (anything with chocolate) and catching up around the dinner table.
Dr. Dana Sarvey is a board certified child, adolescent and adult psychiatrist who has devoted her career to the clinical treatment of children and adolescents with complex, co-occurring psychiatric disorders, as well as mentoring and teaching child psychiatrists-to-be who are still in training. Prior to coming to InStride, Dr. Sarvey served as the Associate Program Director of the ART (Adolescent Acute Residential Treatment Program) and the Adolescent PHP (Partial Hospital Program) at McLean Hospital for almost a decade. During her time there, she helped develop a virtual-based Partial Hospital Program for Adolescents. She also continues to serve as an Instructor in Psychiatry at Harvard Medical School and has published numerous peer-reviewed journal articles, has delivered regional, national and international talks, and has provided training to hospitals, schools, and the community on salient topics of child mental health.
Dr. Sarvey’s commitment to bridging the gap within the child and adolescent mental health community as well as her interest in using technology to help clinicians deliver better care has been fully realized since coming to InStride Health as Medical Director. She enjoys being creative and innovative in how she connects with and treats patients and families. She is also interested in helping to shape and build a supportive and specialized community of clinicians, dedicated to delivering high quality care to the children and adolescents with primary anxiety disorders and OCD.
As a busy mother of two school-aged children and a new puppy, Dr. Sarvey’s favorite non-work activities include: gardening, cooking with her son, designing art projects with her daughter, hiking with the family dog, and meeting with her neighbors for a monthly book club and discussion group.
Sheree started her career at the Adolescent Residential Treatment Center at McLean Psychiatric Hospital where she first discovered the pressing need for innovative solutions for youth mental health treatment. She realized that she was seeing the same children cycling through the residential setting, making significant progress in treatment, only to return to home and school where the lack of well-rounded care was evident.
It became clear to Sheree that schools and parents needed help in supporting these children. She went on to become a Social/Emotional Special Educator and developed two evidence-based therapeutic programs in public schools. Through these programs, Sheree provided school-based mental health support that has changed the trajectory for dozens of children and families.
Sheree is dedicated to helping solve the mental health crisis—and she joined InStride to help build a company that focuses on compassionate care and superior outcomes for kids, teens and their families.
Dr. Wilmer is a board-certified cognitive behavioral psychologist who specializes in the treatment of anxiety, obsessive-compulsive disorder (OCD), and related disorders. Throughout her career, she has been dedicated to providing evidence-based anxiety treatment to children, adolescents, and young adults, and she has extensive experience in individual, parent-focused, and group therapy in outpatient and intensive clinical settings. Dr. Wilmer earned her undergraduate degree in Psychological & Brain Sciences from Dartmouth College and her doctorate in Clinical Psychology from Temple University. She completed her clinical internship and postdoctoral fellowship at McLean Hospital, where she provided intensive exposure-based cognitive behavioral therapy (CBT) for children with anxiety. In addition to her clinical work, Dr. Wilmer has published her research in peer-reviewed journals, delivered talks at national conferences, and provided training to schools and the community.
Dr. Wilmer joined InStride to be part of the solution to the current mental health crisis and is passionate about InStride’s mission of making high-quality, evidence-based care more accessible and affordable for children, adolescents, and young adults struggling with anxiety and OCD.
Outside of InStride, Dr. Wilmer enjoys taking hikes with her husband, son, and dog, or on rainy days, curling up with a good mystery novel.
Dr. Stone is a licensed psychologist who specializes in the treatment of childhood anxiety disorders, obsessive compulsive disorder (OCD), and related disorders. Throughout his training and career, Dr. Stone has focused on providing evidence-based assessment and treatment to children, families, and young adults. He earned a BA in psychology at the University of Massachusetts, Boston, and a doctorate in counseling psychology at Northeastern University. Dr. Stone completed his clinical internship in behavioral psychology at Kennedy Krieger Institute and Johns Hopkins University, and his postdoctoral fellowship in behavioral psychology and neuropsychology at McLean Hospital and Harvard Medical School, during which he provided intensive exposure-based treatment to children with anxiety and related disorders. Dr. Stone is currently an Instructor of Psychology in the Department of Psychiatry at Harvard Medical School and a psychologist at the McLean Anxiety Mastery Program, where he conducts research and development on electronic therapy interventions, such as telehealth and virtual reality therapies. As Associate Director of Digital Health Innovation at InStride, Dr. Stone combines his knowledge of psychological assessment and intervention, with his passion for science and technology to drive forward the development and implementation of new therapeutic techniques to combat the pediatric mental health crisis.
Dr. Stone joined InStride to help develop and implement evidence-based, and insurance-based, therapy to combat the pediatric mental health crisis and provide affordable care to children, adolescents, and families with anxiety disorders and OCD.
In his free time, Dr. Stone writes, produces, and records music for himself and other artists. He enjoys spending time cooking and walking through the arboretum with his wife and son.
Before joining InStride Health, John Voith drew from his extensive hands-on experience in health care to drive the vision and execution needed for a paradigm shift in oral healthcare delivery as the co-founder and CEO of Virtudent. He helped grow Virtudent from a concept of on-site dental care to a national company in partnership with the leading commercial insurance companies.
Voith also served as operator and general manager of Athenahealth, managing more than 150 people who were focused on improving how doctors connect electronically with each other, their teams and their patients. His leadership helped contribute to the company’s growth from $100 million to over $1 billion in revenue, transforming it from a virtually unknown company to one of the top three players in its space.
With three children, John understands the vital importance of pediatric mental health. He co-founded InStride Health as part of his commitment to making a tangible, positive difference in the lives of children with anxiety and their families.
James is a technology leader, software engineer and serial entrepreneur with over 30 years of experience. He has developed desktop and mobile applications, large scale client-server systems, internet web applications, services and APIs (application programming interfaces). Prior to InStride Health, he co-founded Corvus Insurance and helped design and develop their customer-friendly digital data platform called the CrowBar.
James was also the founding CTO at Iora Health, an innovative value-based health care provider that raised over $120 million in venture funding during his tenure, launching dozens of medical practices throughout the United States, and growing the company to 500 employees. Prior to that, he was the co-founder and chief technology officer of Gazelle, the leading electronics re-Commerce site, winning CNET Best of the Web.
James co-founded InStride to help transform the way traditional care is delivered, helping support children with anxiety and their families when, where, and how they need it.
Eileen has devoted the last twenty years of her career to expanding and improving healthcare delivery. Most recently, Eileen led Optum’s Global EAP business, providing critically needed emotional support services to 20 million members in over 150 countries. Prior to that, Eileen led Anthem’s (now Elevance Health) Clinical Product organization, overseeing eight major product lines. Her mission has been to improve access, increase engagement, and maximize satisfaction and results. She previously served as Chief Operating Officer for The Health & Wellness Institute, a wholly-owned health and wellbeing subsidiary of BCBSRI. She began her career focused on mergers and acquisitions across consulting and investment banking.
Eileen has watched with frustration as the pediatric mental health crisis has worsened each year, with demand far outstripping availability of services. She is thrilled to be a part of the InStride team and help close that gap, providing children and teens with the high-quality, evidence-based treatment they deserve to live happy and fulfilling lives.
Eileen and her husband, Ben, are parents to three wonderful teens/young adults. In their free time as a family, they enjoy traveling to new and exciting places, and meeting people from all over the world. Eileen is also an avid reader, and looks forward to ending each day curled up with a good book.
Danielle van der Lelie joined InStride Health with a passion for helping kids and families find access to critically needed mental health care. As Chief of Staff, Danielle focuses on driving value across InStride’s culture, people, growth, strategy, finance, and investor relations. Danielle joined InStride by way of Oxeon Partners, where she helped build and scale venture and private equity-backed healthcare companies. Specifically, Danielle helped build out the leadership teams for value based care companies like Cityblock, Eleanor Health, Alignment Healthcare, and Strive Health, to name a few. Notably, she helped co-found and launch one of Oxeon Ventures’ latest de novos, Hopscotch Health, a provider of advanced primary care to rural communities. In addition, Danielle helped lead Oxeon’s Breaking Into the Boardroom program, a joint venture partnership with Deerfield Management and Welsh, Carson, Anderson, and Stowe to help promote greater representation of female healthcare executives on boards within the public, private, and nonprofit sectors.
Throughout her career, Danielle has always been driven by the desire to make a difference in people’s lives. She completed her undergraduate degree in Psychobiology at UCLA (Go Bruins!) and was an avid volunteer at UCLA Ronald Reagan Medical Center. She couldn’t be more excited to bring that passion to InStride in order to reach more children and families and help them live healthier lives.
A native of Belgium, Danielle loves spending time abroad with her family across Europe and the Middle East. When she’s not traveling outside of the country, you can usually find her exploring Manhattan’s best new restaurants, workout studios, and book stores.
Mike has been involved in Finance operations for over 15 years, specializing in Financial Planning & Analysis, Accounting, and Technical Accounting. He has experience creating strong teams with disciplined financial analysis to help transform that data into actionable insights.
Mike currently serves as the Vice President of Finance for InStride Health. He joined the team as the first finance hire and is focused on building out a best-in-class finance organization, focusing on delivering revenue and margin success through budget discipline and data insights.
Prior to joining InStride, Mike was a Director of Financial Planning & Analysis at athenahealth where lead a large team that oversaw the budgets for the COO, CTO, CPO offices and various other groups. Throughout his years at athena, Mike managed financial teams as the company went public, and transferred ownership between private entity firms. During his time at athena, Mike also was involved in many strategic initiatives and M&A activities as the company grew from $100M to $2B in revenue.
Mike has a B.S. in Finance from Bentley University and in his free time enjoys skiing, fishing, and the outdoors with his friends and family.
Martha has deep experience in the US insurance market running large businesses while helping new and innovative companies grow. Previously she was President of Aetna’s Global Benefits business and the New England market. She is currently on the board of PsychHub, Alma, Ascellus, and Coriell Life Sciences. She is also an advisor to several companies and is part of HPIR (Health Plan Innovation Roundtable). She brings deep relationships within the US insurance market and throughout the US provider space.
Scott L. Rauch, MD, is president, psychiatrist in chief, and Rose-Marie and Eijk van Otterloo Chair of Psychiatry at McLean Hospital. He is also professor of psychiatry at Harvard Medical School as well as chair of System Behavioral and Mental Health for Mass General Brigham. Dr. Rauch is past president and current secretary of the Society of Biological Psychiatry and was recently elected to membership of the National Academy of Medicine. He has also served in leadership roles for the Anxiety and Depression Association of America as well as the National Network of Depression Centers.
His principal research interests relate to neuroimaging and the neurobiology of affective disorders. Dr. Rauch and colleagues have been leaders in delineating the neurocircuitry of anxiety disorders as well as pioneers in using modern technology, including brain stimulation, neurosurgery, and internet-based methods, to develop novel treatments for anxiety and mood disorders. Dr. Rauch has won numerous awards for his mentorship and research accomplishments, including from Harvard Medical School, the American Psychiatric Association, and the American College of Neuropsychopharmacology.
Dr. Gold oversees all of the hospital’s clinical programs across multiple sites, age groups and levels of care. Dr. Gold serves as the physician leader of McLean’s Schwartz Center Rounds to promote compassionate care giving and support to caregivers. He is also a member of the Executive Committee of the MGH-McLean Child Psychiatry Residency Training Committee.
In addition, Dr. Gold helped to design and serves as statewide associate medical director of the Massachusetts Child Psychiatry Access Project (MCPAP). This innovative consultation support for primary care pediatricians covers over 1,400,000 youths in the Commonwealth.
As senior vice president of strategy, Catharyn Gildesgame, MBA, provides leadership for developing, communicating, and executing hospital strategies that strengthen McLean’s ability to meet its mission, achieve its vision, and effectively respond to opportunities and challenges.
Ms. Gildesgame initially came to McLean to guide the implementation of the 2008 strategic plan. Before coming to McLean in 2009, she served in leadership roles at Mass General Brigham (formerly Partners HealthCare), Massachusetts General Hospital, and Boston Children’s Hospital. Ms. Gildesgame has led numerous teams at McLean, Massachusetts General Hospital, and Mass General Brigham that have received Partners in Excellence Awards.
Kerry J. Ressler, MD, PhD, is chief scientific officer and James and Patricia Poitras Chair in Psychiatry at McLean Hospital. He is also a professor in psychiatry at Harvard Medical School and past-president of the Society for Biological Psychiatry. Dr. Ressler was previously an investigator of the Howard Hughes Medical Institute and is a member of the National Academy of Medicine.
Dr. Ressler’s lab focuses on translational research bridging molecular neurobiology in animal models with human genetic research on emotion, particularly fear and anxiety disorders. He has published over 350 manuscripts ranging from basic molecular mechanisms of fear processing to understanding how emotion is encoded in a region of the brain called the amygdala, in both animal models and human patients.
Dr. Barlow received his PhD from the University of Vermont in 1969 and has published over 650 articles and chapters and over 90 books and clinical manuals, mostly in the areas of anxiety and related emotional disorders, sexual problems, and clinical research methodology.
He is formerly Professor of Psychiatry at the University of Mississippi Medical Center and Professor of Psychiatry and Psychology at Brown University, and founded clinical psychology internships in both settings.
He was also Distinguished Professor in the Department of Psychology at the University at Albany, State University of New York and Director of the Phobia and Anxiety Disorders Clinic at the University at Albany, SUNY. He joined Boston University in 1996.
If you have a question or comment.
If you are ready to start the application process.